GlassScriptPhysician profile
Mark J Amsbaugh
NPI 1245598168
$2,838.22
in general payments reported to CMS, 2019-2025
9 companies · $560 in 2025
The $560 reported for 2025 was more than what 77% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $128 · 2022: $219 · 2023: $414 · 2024: $1,392 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,499 · Travel and Lodging: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.07 |
| Travel and Lodging | $866.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $2,118.03 | 2021-2025 | Icotec Blackarmor Spine System, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm |
| Siemens Medical Solutions USA, INC. | $198.09 | 2022-2024 | Aria Radiation Therapy Management Software, Somatom Go.Top |
| Novocure INC. | $150.05 | 2022 | |
| Boston Scientific Corporation | $124.70 | 2019 | |
| Globus Medical, INC. | $100.63 | 2024 | Excelsius Deformity |
| Tactile Systems Technology INC | $92.02 | 2025 | Flexitouch Plus, Nimbl |
| Avanos Medical | $23.83 | 2022 | |
| Curonix LLC | $17.66 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Carbofix Spine INC | $13.21 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Amsbaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.